Wrays has an active patent prosecution and contentious practice. Recent clients include iCeutica, Amgen, Eli Lilly & Co, Wesfarmers, Orbital Australia and Minara Resources. The four patent leaders are Gary Cox, Todd Shand, Peter Caporn and Scott Vile. The firm is acting for Western Australian minerals project developer Neometals, handling its patent drafting, filing and prosecution. Listed biotechnology company Dimerix has entrusted the team for its IP strategy, patent drafting and prosecution.
Wrays has a thriving non-contentious and contentious trade mark practice, employing an end-to-end IP solution for clients. It follows the clients through the life cycle of its IP rights, from securing the rights to commercialising and enforcing them. Clients include Amgen, Perrigo, Motorola, Samsung, Wilson Parking and Australian Wool Innovation.
The key contacts for soft IP are chairman and principal Gary Cox and trade mark and brand protection specialist Jennifer McEwan.
In the last year, the team provided trade mark portfolio management, and protection and strategy advice to Sirtx Medical, Cash Converters, Australia Made Campagin and Bunnings Group. In an opposition, the firm successfully acted for Lab Brands before the Registrar of Trade Marks in relation to two trade mark opposition proceedings.
Principal Andrew Butler departed during the research period for DC Collins.